[ad_1] ZURICH (Reuters) – The hopes of the Roche pharmaceutical company to recover the Swiss influenza market have been reinforced after an advanced phase study showed that its experimental drug, baloxavir marboxil, …
Read More »[ad_1] ZURICH (Reuters) – The hopes of the Roche pharmaceutical company to recover the Swiss influenza market have been reinforced after an advanced phase study showed that its experimental drug, baloxavir marboxil, …
Read More »